Affinage

CCNF

Cyclin-F · UniProt P41002

Length
786 aa
Mass
87.6 kDa
Annotated
2026-06-09
22 papers in source corpus 13 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

Cyclin F (CCNF/FBXO1) is the substrate-recognition subunit of an SCF(Cyclin F) E3 ubiquitin ligase that controls protein homeostasis through K48-linked ubiquitination and proteasomal turnover of its substrates (PMID:27080313, PMID:36607545). It binds the E2F1/E2F2/E2F3a transcription factors via R/I and R/V degron motifs in their dimerization domains and targets them for K48-linked degradation, with MEK/ERK-mediated phosphorylation near these degrons regulating the interaction and thereby gating the G1/S cell cycle transition (PMID:36607545); it also recognizes RRM2 as a substrate (PMID:34201347) and, in an antiviral role, binds and degrades HIV-1 Vif through a Vif C-terminal motif to restore APOBEC3G and suppress virion infectivity (PMID:28184007). Beyond its ligase activity, Cyclin F directly binds VCP through its N-terminal region and colocalizes with VCP in the nucleus, enhancing VCP ATPase activity without ubiquitylating it (PMID:31577344). Cyclin F is itself a degradation target of the FBXL8 and FZR1 ligases (PMID:34201347). ALS/FTD-associated CCNF mutations (notably S621G) disrupt this homeostatic machinery: they drive cytoplasmic mislocalization of Cyclin F, increase VCP ATPase activity, promote cytoplasmic TDP-43 aggregation, and perturb Lys48-ubiquitylation and free-ubiquitin balance in a manner requiring intact SCF ligase activity (PMID:27080313, PMID:31577344, PMID:37220877). Mutant Cyclin F impairs autophagosome-lysosome fusion and physically interacts with p62/SQSTM1 (PMID:28852778), activates caspase-3-mediated apoptosis (PMID:28444311, PMID:33986643), and—through a non-cell-autonomous astrocyte mechanism—suppresses motor neuron excitability and sodium currents (PMID:42069601), establishing CCNF as a causative gene in ALS/FTD pathogenesis.

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1994 Low

    Established CCNF as a distinct cyclin-family gene, defining the molecule whose function would later be dissected.

    Evidence cDNA sequencing and Northern blot mapping CCNF to chromosome 16p13.3

    PMID:7896286

    Open questions at the time
    • No functional mechanism established
    • No substrates or complex membership defined
  2. 2016 High

    Connected CCNF to neurodegeneration by showing mutant Cyclin F disrupts ubiquitination homeostasis, addressing how an SCF subunit could drive disease.

    Evidence Transfection of mutant CCNF in neuronal cells with ubiquitination and substrate-accumulation assays

    PMID:27080313

    Open questions at the time
    • Did not resolve which degradation steps are directly impaired
    • Causal substrate spectrum not fully defined
  3. 2017 Medium

    Defined the consequences of mutant Cyclin F on autophagy and on a viral substrate, broadening the substrate landscape of SCF(Cyclin F).

    Evidence Lys48-ubiquitylation proteomics, Co-IP with p62 and autophagy-marker analysis (Neuro-2A/SH-SY5Y); Co-IP, degron mutagenesis, and ubiquitination assays for HIV-1 Vif; zebrafish caspase-3 and motor-axon readouts

    PMID:28184007 PMID:28444311 PMID:28852778 PMID:29102476

    Open questions at the time
    • Mechanistic link between autophagy block and ligase activity not isolated
    • Vif degradation not validated beyond a single lab
    • Apoptosis readouts correlative in some models
  4. 2019 High

    Identified a ligase-independent function of Cyclin F as a VCP ATPase enhancer and tied mutation-driven mislocalization to TDP-43 aggregation.

    Evidence Co-IP, deletion mapping, in vitro ATPase assay, subcellular fractionation, and TDP-43 aggregation assays

    PMID:31577344

    Open questions at the time
    • Physiological role of VCP enhancement in vivo unclear
    • How elevated VCP activity causes TDP-43 mislocalization not mechanistically resolved
  5. 2021 Medium

    Placed Cyclin F within its own regulatory turnover circuit and added RRM2 as a substrate, clarifying upstream control of Cyclin F levels.

    Evidence Pulldown and double-knockdown of FBXL8/FZR1, plus RRM2 pulldown and overexpression protein-level analysis

    PMID:34201347

    Open questions at the time
    • Direct ubiquitination of Cyclin F by FBXL8/FZR1 not shown
    • RRM2 ubiquitination not directly demonstrated
  6. 2021 Medium

    Generalized mutation-driven apoptosis activation across multiple ALS variants and patient-derived cells.

    Evidence Label-free quantitative proteomics in HEK293 and iPSC-derived cells with immunoblot validation

    PMID:33986643

    Open questions at the time
    • Causal chain from UPS disruption to apoptosis not defined
    • Single lab
  7. 2023 High

    Demonstrated that SCF(Cyclin F) ligase activity is required for ubiquitin homeostasis and mapped the E2F degron mechanism, linking Cyclin F to both proteostasis and cell-cycle control.

    Evidence iPSC-derived motor neurons with ligase-dead rescue mutants and proteasome/free-ubiquitin assays; Co-IP, degron mutagenesis, half-life, kinase-inhibitor and cell-cycle analyses for E2F1/2/3a

    PMID:36607545 PMID:37220877

    Open questions at the time
    • In vivo relevance of E2F regulation in neurons not established
    • How MEK/ERK signaling intersects disease mutations unknown
  8. 2024 Medium

    Established an endogenous developmental requirement for CCNF in motor neurons and a specific sensitivity to ER stress via loss-of-function.

    Evidence CRISPR/TALEN ccnf knockout in zebrafish with motor neuron morphology and stress-response assays

    PMID:38474336

    Open questions at the time
    • Molecular link between Cyclin F and ER stress pathway unresolved
    • Relationship of loss-of-function to gain-of-function mutant phenotypes unclear
  9. 2026 High

    Revealed a non-cell-autonomous astrocyte mechanism by which the S621G mutation suppresses motor neuron excitability, reframing CCNF pathology beyond neuron-intrinsic effects.

    Evidence CRISPR knock-in CcnfS621G mice, iPSC-derived astrocyte/motor-neuron co-culture, mitochondrial and electrophysiology assays

    PMID:42069601

    Open questions at the time
    • Knock-in mice lack overt motor decline at 18 months
    • Astrocyte-secreted mediator suppressing neuron firing not identified

Open questions

Synthesis pass · forward-looking unresolved questions
  • The molecular bridge linking Cyclin F's ligase and VCP-enhancing activities to the cell-type-specific neurodegenerative cascade remains unresolved.
  • No unified model connecting substrate dysregulation, VCP hyperactivity, and astrocyte dysfunction
  • The full physiological substrate repertoire of SCF(Cyclin F) is incomplete

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140096 catalytic activity, acting on a protein 3 GO:0016874 ligase activity 2 GO:0098772 molecular function regulator activity 1
Localization
GO:0005634 nucleus 1 GO:0005829 cytosol 1
Pathway
R-HSA-1643685 Disease 3 R-HSA-392499 Metabolism of proteins 3 R-HSA-1640170 Cell Cycle 1 R-HSA-9612973 Autophagy 1
Complex memberships
SCF(Cyclin F)

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2016 Cyclin F is a component of an SCF(Cyclin F) E3 ubiquitin-protein ligase complex; expression of mutant CCNF in neuronal cells caused abnormal ubiquitination and accumulation of ubiquitinated proteins, including TDP-43 and an SCF(Cyclin F) substrate, implicating protein homeostasis disruption in neurodegeneration. Transfection of mutant CCNF in neuronal cells, ubiquitination assays, identification of ubiquitinated substrates Nature communications High 27080313
2017 ALS/FTD-causing mutant cyclin F (S621G) causes increased Lys48-specific ubiquitylation in neuronal cells, and proteomic analysis identified p62/SQSTM1 and autophagy-related proteins as elevated Lys48-ubiquitylated substrates; mutant cyclin F impairs autophagosome-lysosome fusion and cyclin F physically interacts with p62. Transfection in Neuro-2A and SH-SY5Y cells, Lys48-specific ubiquitylation assays, immunoprecipitation of Lys48-ubiquitylated proteins, proteomics, autophagy marker analysis (p62, LC3, Lamp2) Cellular and molecular life sciences : CMLS Medium 28852778
2017 Cyclin F (FBXO1) physically interacts with HIV-1 Vif protein and mediates its ubiquitination and proteasomal degradation through the SCF(Cyclin F) E3 ligase machinery, thereby restoring APOBEC3G expression and reducing progeny virion infectivity; a cyclin F-specific C-terminal motif in Vif is required for this interaction. Co-immunoprecipitation, gene overexpression and knockdown, ubiquitination assays, mutational analysis of Vif degron motif, APOBEC3G expression analysis The Journal of biological chemistry Medium 28184007
2017 ALS-linked CCNF mutations disrupt cellular pathways including caspase-3-mediated apoptosis; mutant CCNF expression in zebrafish caused increased activated caspase-3, increased spinal cord cell death, shortened primary motor axons, and aberrant axonal branching. Proteomic analysis of in vitro models, transient overexpression of human CCNF in zebrafish embryos, immunostaining for cleaved caspase-3, motor axon morphology assessment, photomotor response assay Human molecular genetics Medium 28444311
2017 Two novel ALS-associated CCNF missense mutations (p.S222P and p.S532R) result in dysfunction of the cyclin F-mediated ubiquitin-proteasome pathway in vitro. In vitro functional studies of ubiquitin-proteasome pathway activity with mutant CCNF constructs Neurobiology of aging Low 29102476
2019 Cyclin F binds to VCP (valosin-containing protein) via its N-terminal region and colocalizes with VCP in the nucleus; VCP is not ubiquitylated by SCF(Cyclin F) but instead its ATPase activity is enhanced by Cyclin F in vitro; ALS-associated CCNF mutations increase Cyclin F binding to VCP, enhance VCP ATPase activity, cause cytoplasmic mislocalization of Cyclin F, and promote cytoplasmic TDP-43 aggregation. Co-immunoprecipitation, deletion mapping, in vitro ATPase assay, subcellular fractionation/localization, transfection experiments, TDP-43 aggregation assay Human molecular genetics High 31577344
2021 Cyclin F is targeted for proteasomal degradation by FBXL8 and FZR1 E3 ligases (both pull down CCNF; double knockdown causes CCNF accumulation); CCNF itself pulls down RRM2 and CCNF overexpression reduces RRM2 protein levels, indicating RRM2 is a substrate of SCF(Cyclin F). Pulldown assays, double knockdown experiments, overexpression studies, protein level analysis Cancers Medium 34201347
2021 Multiple ALS-linked CCNF mutations (K97R, S195R, S509P, R574Q, S621G) activate apoptosis pathways in HEK293 cells and iPSC-derived cells, as revealed by label-free quantitative proteomics and validated by immunoblot. Label-free quantitative proteomics of HEK293 cells and patient-derived iPSCs, immunoblot validation Frontiers in molecular neuroscience Medium 33986643
2023 ALS-linked CCNF S621G mutation causes ubiquitin-proteasome system dysfunction in iPSC-derived motor neurons; both wild-type and S621G CCNF overexpression alter free ubiquitin levels; double mutants designed to abolish E3 ligase complex formation improved UPS function and increased free monomeric ubiquitin, demonstrating that SCF(Cyclin F) ligase activity is required for normal ubiquitin homeostasis. iPSC-derived motor neuron model, proteasome activity assays, ubiquitin level measurement, overexpression of E3 ligase-dead double mutants in NSC-34 cells Human molecular genetics Medium 37220877
2023 FBXO1 (Cyclin F) binds E2F1, E2F2, and E2F3a through R/I and R/V degron motifs in their dimerization domains and mediates K48-linked ubiquitination and proteasomal degradation of these transcription factors; MEK/ERK signaling-mediated phosphorylation of threonine residues near these motifs regulates the FBXO1-E2F interaction and E2F protein stability, thereby controlling G1/S cell cycle transition. Co-immunoprecipitation, ubiquitination assays, half-life measurement, binding domain/degron mutagenesis (RI/AA, RV/AA), specific kinase inhibitor analysis, FBXO1 knockdown, cell cycle analysis Archives of pharmacal research High 36607545
2024 Loss of ccnf in zebrafish (CRISPR/TALEN knockout) causes abnormal motor neuron development and axonal outgrowth defects, and ccnf-deficient zebrafish are specifically sensitized to endoplasmic reticulum stress, identifying a role for CCNF in motor neuron development and ER stress response. CRISPR/Cas9 and TALEN-mediated genome editing in zebrafish, motor neuron morphology analysis, stress response assays Cells Medium 38474336
2026 Endogenous knock-in CcnfS621G mice (generated by CRISPR/Cas9) show no motor decline or neuronal loss at 18 months but display increased hippocampal astrocyte ramification; CCNFS621G iPSC-derived astrocytes exhibit impaired mitochondrial membrane potential and altered network morphology; CCNFS621G astrocytes suppress repetitive motor neuron firing, reduce voltage-gated sodium currents, and increase the proportion of neurons unable to fire action potentials when co-cultured with motor neurons, demonstrating a non-cell-autonomous astrocyte-driven mechanism. CRISPR/Cas9 knock-in mouse model, immunohistochemistry, proteomics, iPSC-derived astrocyte and motor neuron co-culture, mitochondrial membrane potential assay, electrophysiology (action potential and voltage-gated sodium current recording) Journal of neuroinflammation High 42069601
1994 CCNF encodes a new member of the cyclin family (Cyclin F) located on chromosome 16p13.3; it is related to A- and B-type cyclins by sequence; its function was not determined at this time. cDNA sequencing, exon-intron boundary determination, Northern blot analysis Genomics Low 7896286

Source papers

Stage 0 corpus · 22 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2016 CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nature communications 179 27080313
2017 Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy. Cellular and molecular life sciences : CMLS 44 28852778
2017 Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype. Human molecular genetics 40 28444311
2019 Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity. Human molecular genetics 28 31577344
2017 Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery. The Journal of biological chemistry 25 28184007
2021 A Novel Signature of CCNF-Associated E3 Ligases Collaborate and Counter Each Other in Breast Cancer. Cancers 17 34201347
2017 Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China. Amyotrophic lateral sclerosis & frontotemporal degeneration 17 28281833
2017 Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis. Neurobiology of aging 17 29102476
2023 The Skp1-Cullin1-FBXO1 complex is a pleiotropic regulator required for the formation of gametes and motile forms in Plasmodium berghei. Nature communications 15 36898988
2021 Unbiased Label-Free Quantitative Proteomics of Cells Expressing Amyotrophic Lateral Sclerosis (ALS) Mutations in CCNF Reveals Activation of the Apoptosis Pathway: A Workflow to Screen Pathogenic Gene Mutations. Frontiers in molecular neuroscience 14 33986643
1994 A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1). Genomics 14 7896286
2023 MEKs/ERKs-mediated FBXO1/E2Fs interaction interference modulates G1/S cell cycle transition and cancer cell proliferation. Archives of pharmacal research 9 36607545
2019 Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNFS621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming. Stem cell research 8 31445393
2023 Genetic and Phenotypic Spectrum of Amyotrophic Lateral Sclerosis Patients with CCNF Variants from a Large Chinese Cohort. Molecular neurobiology 7 37171577
2023 ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis. Human molecular genetics 6 37220877
2018 Screening for CCNF Mutations in a Chinese Amyotrophic Lateral Sclerosis Cohort. Frontiers in aging neuroscience 6 30008669
2023 CCNF is a potential pancancer biomarker and immunotherapy target. Frontiers in oncology 3 37168372
2024 Zebrafish CCNF and FUS Mediate Stress-Specific Motor Responses. Cells 2 38474336
2023 Behavioural Variant Frontotemporal Dementia due to CCNF Gene Mutation: A Case Report. Current Alzheimer research 1 37872794
2026 ALS-FTD-linked CCNFS621G drives increased hippocampal astrocyte ramification and mitochondrial dysfunction and impairs motor neuron excitability. Journal of neuroinflammation 0 42069601
2025 Expanding the genetic spectrum of corticobasal syndrome: novel CCNF p.M394L variant from a South Asian cohort. Neurocase 0 41069067
2024 Exploring the Role of CCNF Variants in Italian ALS Patients. Genes 0 39766833

Missed literature

Know a paper Affinage missed for CCNF? Flag it for the maintainers and the community.

No submissions yet.